Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Biochemistry|October 10, 1995
Intermolecular interactions between protein C inhibitor and coagulation proteasesS T Cooper, H C Whinna, T P Jackson, et al.Thrombosis and Haemostasis|May 1, 1996
Role of the A+ helix in heparin binding to protein C inhibitorM G Elisen, M H Maseland, F C Church, et al.The Journal of Biological Chemistry|February 15, 1993
Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombinJ E Phillips, R A Shirk, H C Whinna, et al.The Journal of Biological Chemistry|April 6, 2000
Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaqueR A Shirk, N Parthasarathy, J D San Antonio, et al.The Journal of Biological Chemistry|June 15, 1987
Identification of a lysyl residue in antithrombin which is essential for heparin bindingC B Peterson, C M Noyes, J M Pecon, et al.The Journal of Biological Chemistry|April 10, 1984
Identification of "embryonin" as bovine alpha 2-macroglobulinS R Feldman, S L Gonias, K A Ney, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna, E B Lesesky, D M Monroe, et al.Journal of Thrombosis and Haemostasis : JTH|July 20, 2007
Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulinY M Fortenberry, H C Whinna, S T Cooper, et al.Journal of Thrombosis and Haemostasis : JTH|February 26, 2010
Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cellsJ C Carter, R A Campbell, J A Gibbons, et al.Pageof 8